Royal Bank of Canada’s Aura Biosciences AURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $242K | Buy |
38,632
+33,689
| +682% | +$211K | ﹤0.01% | 4677 |
|
|
2025
Q1 | $29K | Sell |
4,943
-12,596
| -72% | -$73.9K | ﹤0.01% | 5402 |
|
|
2024
Q4 | $144K | Buy |
17,539
+11,799
| +206% | +$96.9K | ﹤0.01% | 4630 |
|
|
2024
Q3 | $50K | Buy |
5,740
+524
| +10% | +$4.56K | ﹤0.01% | 5235 |
|
|
2024
Q2 | $39K | Buy |
5,216
+3,562
| +215% | +$26.6K | ﹤0.01% | 5375 |
|
|
2024
Q1 | $13K | Sell |
1,654
-8,802
| -84% | -$69.2K | ﹤0.01% | 5639 |
|
|
2023
Q4 | $92K | Buy |
10,456
+5,004
| +92% | +$44K | ﹤0.01% | 5134 |
|
|
2023
Q3 | $49K | Buy |
5,452
+1,586
| +41% | +$14.3K | ﹤0.01% | 5305 |
|
|
2023
Q2 | $47K | Buy |
3,866
+2,543
| +192% | +$30.9K | ﹤0.01% | 5358 |
|
|
2023
Q1 | $12K | Sell |
1,323
-1,358
| -51% | -$12.3K | ﹤0.01% | 5838 |
|
|
2022
Q4 | $28K | Buy |
2,681
+2,458
| +1,102% | +$25.7K | ﹤0.01% | 5684 |
|
|
2022
Q3 | $4K | Buy |
223
+120
| +117% | +$2.15K | ﹤0.01% | 6299 |
|
|
2022
Q2 | $1K | Sell |
103
-242
| -70% | -$2.35K | ﹤0.01% | 6617 |
|
|
2022
Q1 | $8K | Sell |
345
-813
| -70% | -$18.9K | ﹤0.01% | 6550 |
|
|
2021
Q4 | $19K | Buy |
+1,158
| New | +$19K | ﹤0.01% | 6289 |
|